# Trade Mark Journal No.2026/006 6 February 2026

## WO0000001877695 (9,16,35,38,41,42,44)

Office of origin: United States of America

Date of International Registration:16 May 2025
Date of designation in the UK: 16 May 2025

International priority date claimed: 17 December 2024 (United States of America) (98908406)

Class 9
  Downloadable children's books; downloadable children's booklets; downloadable children's activity books; downloadable newsletters; downloadable computer software games.
Class 16
  Printed children's books; printed children's booklets; printed activity books; printed newsletters in the field of endocrine diseases and disorders.
Class 35
  Administering a patient support program to coordinate access to medicines; administering a patient support program to provide pharmaceutical co-pay assistance; administering a patient support program to provide general education and support and information about available resources for patients, caregivers and healthcare providers; administering a patient support program to provide and assist with insurance coverage and reimbursement information; promoting awareness of congenital adrenal hyperplasia including via a public platform to discuss congenital adrenal hyperplasia and coping strategies; promoting awareness of adrenal insufficiency including via a public platform to discuss adrenal insufficiency and coping strategies; promoting awareness of endocrine diseases and disorders including via a public platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; promoting the interests of people who have endocrine diseases and disorders and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders.
Class 38
  Providing an online forum in the field of health and pharmaceuticals.
Class 41
  Educational services; providing mentorship programs in the field of health and pharmaceuticals; providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders.
Class 42
  Providing information about medical research; providing medical research information in the field of pharmaceuticals and congenital adrenal hyperplasia; providing medical research information in the field of pharmaceuticals and adrenal insufficiency; providing medical research information in the field of pharmaceuticals and endocrine diseases and disorders; providing software services enabling the creation of an online community for users for the purpose of participating in discussions in the fields of health, pharmaceuticals, and coping strategies.
Class 44
  Providing medical information; providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to patients, medical professionals, and insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of congenital adrenal hyperplasia; online information services, namely, providing medical information in the field of adrenal insufficiency; online information services, namely, providing medical information in the field of endocrine diseases and disorders.

Neurocrine Biosciences, Inc.

Representative: Mishcon De Reya LLP, Africa House, 70 Kingsway London WC2B 6AH UNITED KINGDOM